1
Benjamin Oshlack, James McGinity, Mark Chasin, Roland Bodmeier: Controlled release coatings derived from aqueous dispersions of zein. Euroceltique, Steinberg Raskin & Davidson, October 18, 1994: US05356467 (237 worldwide citation)

Stable aqueous dispersions of zein which may be used as controlled release coatings of pharmaceutical, animal, health, or food products in an inorganic solvent-free environment are disclosed, as well as methods for preparing the same.


2
Benjamin Oshlack, Mark Chasin, James McGinity, Roland Bodmeier: Aqueous dispersions of zein and preparation thereof. Euroceltique, Steinberg Raskin & Davidson, June 28, 1994: US05324351 (151 worldwide citation)

Aqueous dispersions of zein which may be used in the coating of pharmaceutical, animal, health, or food products in an inorganic solvent-free environment are disclosed, as well as methods for preparing the same.


3
Ze&apos ev Shaked, James McGinity: Pharmaceutical formulation containing DFMO for the treatment of cancer. ILEX Oncology, Fulbright & Jaworski, August 21, 2001: US06277411 (3 worldwide citation)

Preparations comprising a capsule, tablet or other dosage form containing a core of different types of DFMO are provided. These preparations are capable of providing for the direct and constant delivery of DFMO to the entire GI tract or just the colon and rectum. The DFMO-containing granules include ...


4
Benjamin Oshlack, Mark Chasin, James Mcginity: Aqueous dispersions of zein and preparation thereof. Steinberg And Raskin, ZHANG MINGYU, May 4, 1994: CN93109806

Aqueous dispersions of zein which may be used in the coating of pharmaceutical, animal, health, or food products in an inorganic solvent-free environment are disclosed, as well as methods for preparing the same.


5
Ze aposev Shaked, James McGinity: Pharmaceutical formulation containing DEMO for the treatment of cancer. Ilex Oncology, Steven L Highlander Esq, Fulbright & Jaworski, August 15, 2002: US20020110590-A1

Preparations comprising a capsule, tablet or other dosage form containing a core of different types of DFMO are provided. These preparations are capable of providing for the direct and constant delivery of DFMO to the entire GI tract or just the colon and rectum. The DFMO-containing granules include ...



Click the thumbnails below to visualize the patent trend.